Acotec Scientific Holdings Limited announced that on March 23, 2023, the Group received the registration approvals from the Food and Drug Administration of Thailand for Vericor, a peripheral support catheter designed to enhance access to peripheral vessels. Vericor is used together with guidewires to recanalize chronic total occlusion (CTO) lesions and below-the-knee ("BTK") lesions and to reduce the difficulty of performing surgeries on complex lesions and BTK lesions. The Company will carry out marketing activities when appropriate.